In agreement with these observations, the NGF/TrkA axis has been recently reported to promote the acquisition of a more aggressive phenotype in different miniaturized 3D PCa systems, suggesting that targeting of this cascade might be of value in the clinical approach of both hormone-driven and -refractory malignancies [49]. The gene discussed is NGF; the disease is posterior cortical atrophy.